RDY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Dr Reddy's Laboratories Ltd (RDY) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock lacks clear positive catalysts, has weak financial performance, and no significant trading signals. A 'hold' is recommended until stronger growth signals or catalysts emerge.
The MACD histogram is negative and expanding (-0.0485), indicating bearish momentum. RSI is neutral at 40.333, and moving averages are converging, showing no clear trend. The stock is trading near key support (S1: 14.104) and resistance (R1: 14.723), suggesting limited immediate upside potential.
No significant positive catalysts identified. Hedge funds and insiders are neutral, and there are no recent news or event-driven catalysts.
Financial performance is weak, with YoY declines in revenue (-1.02%), net income (-18.84%), EPS (-20%), and gross margin (-8.61%). Technical indicators suggest bearish momentum, and no significant trading signals are present.
In Q3 2026, the company reported declining financial metrics: Revenue dropped to $979.8M (-1.02% YoY), Net Income dropped to $135.8M (-18.84% YoY), EPS dropped to $0.16 (-20% YoY), and Gross Margin dropped to 53.63% (-8.61% YoY).
No recent analyst rating or price target changes available.
